MOREL: Multicenter observational study on treatment and PD-L1 testing in patients (pts) with newly diagnosed stage IV NSCLC in Spain

dc.conference.dateDEC 09-12, 2020
dc.conference.titleESMO Immuno-Oncology Virtual Congress
dc.contributor.authorRubio-Viqueira, B.
dc.contributor.authorMajem Tarruella, M.
dc.contributor.authorLazaro, M. E.
dc.contributor.authorVazquez Estevez, S.
dc.contributor.authorCordoba-Ortega, J. F.
dc.contributor.authorMaestu Maiques, I.
dc.contributor.authorGarcia Gonzalez, J. J.
dc.contributor.authorBlasco Cordellat, A.
dc.contributor.authorValdivia-Bautista, J.
dc.contributor.authorGonzalez Arenas, C.
dc.contributor.authorSanchez Torres, J. M.
dc.contributor.authoraffiliation[Rubio-Viqueira, B.] Hosp Univ Quironsalud Madrid, Dept Med Oncol, Madrid, Spain
dc.contributor.authoraffiliation[Majem Tarruella, M.] Hosp Santa Creu & Sant Pau, Dept Med Oncol, Barcelona, Spain
dc.contributor.authoraffiliation[Lazaro, M. E.] Hosp Univ Alvaro Cunqueiro, Dept Med Oncol, Vigo, Pontevedra, Spain
dc.contributor.authoraffiliation[Vazquez Estevez, S.] Hosp Xeral Calde Lugo, Dept Med Oncol, Lugo, Spain
dc.contributor.authoraffiliation[Cordoba-Ortega, J. F.] Hosp Arnau Vilanova, Dept Med Oncol, Lleida, Spain
dc.contributor.authoraffiliation[Maestu Maiques, I.] Hosp Univ Doctor Peset, Dept Med Oncol, Valencia, Spain
dc.contributor.authoraffiliation[Garcia Gonzalez, J. J.] CHUS Complejo Hosp Univ Santiago de Composteia, Dept Oncol Med, Santiago De Compostela, Spain
dc.contributor.authoraffiliation[Blasco Cordellat, A.] Hosp Gen Univ Valencia, Dept Med Oncol, Valencia, Spain
dc.contributor.authoraffiliation[Valdivia-Bautista, J.] Hosp Univ Virgen de las Nieves, Dept Med Oncol, Granada, Spain
dc.contributor.authoraffiliation[Gonzalez Arenas, C.] MSD Merck Sharp & Dohme Espanola SA, Med Oncol, Madrid, Spain
dc.contributor.authoraffiliation[Sanchez Torres, J. M.] Hosp Univ La Princesa, Dept Med Oncol, Madrid, Spain
dc.contributor.funderMerck Sharp Dohme Spain
dc.date.accessioned2025-01-07T14:15:50Z
dc.date.available2025-01-07T14:15:50Z
dc.date.issued2020-12-01
dc.identifier.doi10.1016/j.annonc.2020.10.542
dc.identifier.essn1569-8041
dc.identifier.issn0923-7534
dc.identifier.unpaywallURLhttp://www.annalsofoncology.org/article/S0923753420430558/pdf
dc.identifier.urihttps://hdl.handle.net/10668/26250
dc.identifier.wosID600992500055
dc.issue.number7
dc.journal.titleAnnals of oncology
dc.journal.titleabbreviationAnn. oncol.
dc.language.isoen
dc.organizationSAS - Hospital Universitario Virgen de las Nieves
dc.page.numberS1437-S1438
dc.publisherElsevier
dc.rights.accessRightsopen access
dc.titleMOREL: Multicenter observational study on treatment and PD-L1 testing in patients (pts) with newly diagnosed stage IV NSCLC in Spain
dc.typeconference output
dc.type.hasVersionVoR
dc.volume.number31
dc.wostypeMeeting Abstract

Files